Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,129 | $8,925 | $11,673 | $17,384 |
| - Cash | $434 | $594 | $441 | $311 |
| + Debt | $250 | $259 | $217 | $203 |
| Enterprise Value | $12,945 | $8,590 | $11,449 | $17,276 |
| Revenue | $2,056 | $1,862 | $1,566 | $1,232 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Gross Profit | $1,289 | $1,149 | $948 | $755 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| EBITDA | $530 | $465 | $454 | $347 |
| % Margin | 25.8% | 25% | 29% | 28.2% |
| Net Income | $284 | $246 | $268 | $205 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| % Growth | 975.8% | -15.4% | 14.7% | – |
| Operating Cash Flow | $413 | $284 | $341 | $353 |
| Capital Expenditures | -$169 | -$91 | -$70 | -$56 |
| Free Cash Flow | $244 | $193 | $271 | $297 |